| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2141629 | Lung Cancer | 2012 | 6 Pages |
Abstract
Postoperative morbidity after neoadjuvant chemotherapy is more important in elderly patients. These data should be taken into account when considering the interest of preoperative treatment in elderly patients with resectable NSCLC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Caroline Rivera, Jacques Jougon, Marcel Dahan, Pierre-Emmanuel Falcoz, Alain Bernard, Laurent Brouchet,